As Hi-Tech Argues For DMHA Use, DMAA Seizure Falls In FDA's Criminal Case, Contempt Stands In FTC Complaint

Hi-Tech Pharmaceuticals granted motion in federal court to have $19m in seized DMAA products returned, though the order noted sales of the products are prohibited. As Hi-Tech seeks court order that FDA is wrong about DMAA, an appellate court upholds $40m contempt fine against firm in FTC complaint.

A firm involved in frequent disputes with the US Food and Drug Administration seeks a court order that the stimulant DMHA is a dietary ingredient as the agency warns another firm about using it in supplements.

On 1 October, the FDA published a warning letter advising Alternative Laboratories Inc., that its coffee, cocoa and other beverage...